[1]
J. F. Hofmann, PhD, A. Lal, MSc, MBA, M. Steffens, and R. Boettger, “Patient-relevant outcomes and health-related quality of life in patients with chronic, severe, noncancer pain treated with tapentadol prolonged release—Using criteria of health technology assessment”, J of Opioid Management, vol. 12, no. 5, pp. 323–331, Sep. 2016.